Prime Editing Explained: How It Works, Recent Breakthroughs, and Future Uses

A single typo in DNA can change a life. Some genetic diseases come down to one misplaced “letter” in a person’s genome. For decades, scientists have wanted a way to fix those errors with the same care a person uses to correct a sentence, not by tearing up the whole page.

That is the promise of prime editing.

Prime editing is a newer form of gene editing designed to make precise DNA changes without cutting both strands of the DNA helix. It can swap one DNA letter for another, insert short sequences, or delete small stretches of DNA.

The science is still young. Prime editing is not a cure-all, and many uses remain experimental. Even so, it has quickly become one of the most watched tools in genetics because it may solve some of the safety and precision challenges that come with earlier editing methods.

Prime editing aims to correct DNA with fine control rather than broad disruption.

What prime editing is

Prime editing is a gene-editing method first reported in 2019 by researchers led by David Liu at the Broad Institute. It builds on CRISPR technology, but it works in a more controlled way than the best-known CRISPR-Cas9 approach.

To understand it, picture DNA as a long instruction manual written with four chemical letters:

• A

• C

• G

• T

  
  

Many genetic conditions happen when one or more of these letters are changed, missing, or added in the wrong place. Prime editing gives scientists a way to rewrite selected letters with high precision.

The system has two main parts.

A modified Cas9 enzyme

Traditional CRISPR-Cas9 acts like molecular scissors. It cuts both strands of DNA at a target site. Prime editing uses a modified version called a nickase, which cuts only one DNA strand.

A prime editing guide RNA

This guide is often called a pegRNA, short for prime editing guide RNA. It does more than guide the editor to the right location. It also carries the new genetic text that the cell should copy into the DNA.

Prime editing also includes a reverse transcriptase enzyme. This enzyme reads the edit written in the pegRNA and uses it as a template to write new DNA at the target site.

Put simply, the process looks like this:

1. The guide RNA brings the editor to a specific DNA sequence.

2. The modified Cas9 nicks one DNA strand.

3. Reverse transcriptase copies the desired edit into the DNA.

4. The cell’s own repair systems help install the change.

   
   

That combination lets prime editing perform many small edits without fully breaking the DNA.

PE, consisting of a Cas9 (green) and reverse transcriptase (purple), located at a target DNA site (black) by the pegRNA (brown), including the primer binding site (red) and reverse transcriptase template, consisting of the intended edit (yellow) and homology arm (blue) (A). Once the spacer has annealed the target site and a nick is introduced, the PBS can associate upstream of the cut site (B) and prime the reverse transcriptase to transcribe the repair template into the break (C). Competition between the newlysynthesized flap and the WT flap for binding the target site ensues (D) until the edited flap is integrated and the WT flap is excised. A second nick introduced downstream of this (E) can improve the edit integration across both DNA strands (F). Created with BioRender.com. Source: Reproduced from Lushington C, Thomas P, Adikusuma F. A primer on prime: A prime editing update from advances to first-in-human trial. Molecular Therapy. 2026;34(6):3171–3191. Licensed under CC BY

How prime editing differs from traditional gene editing

Prime editing is part of the CRISPR family, but it does not behave like classic CRISPR-Cas9. The differences matter because they affect accuracy, safety, and what kinds of edits are possible.

Method	How it works	What it can do well	Main limitation
Traditional CRISPR-Cas9	Cuts both DNA strands at a target site	Disrupts genes or creates space for a repair template	Can cause unwanted insertions, deletions, or larger DNA changes
Base editing	Chemically changes one DNA letter into another	Makes certain single-letter changes without double-strand breaks	Limited to specific types of letter swaps
Prime editing	Nicks one strand and writes a new sequence from a guide RNA template	Makes many substitutions, small insertions, and small deletions	Delivery and efficiency still vary by cell type and target

Classic CRISPR-Cas9 is powerful, but a double-strand break can be harmful to a cell. The cell must repair the break, and that repair can produce unpredictable changes. This can be useful if the goal is to turn off a gene. It is less ideal when the goal is to correct one exact mutation.

Base editing, another major advance, avoids double-strand breaks and can fix certain single-letter errors. For example, some base editors can change C to T, or A to G. That is useful, but it does not cover every possible edit.

Prime editing has a broader editing range. In principle, it can make all 12 possible single-letter DNA substitutions. It can also add or remove short DNA sequences. That makes it more flexible than base editing and potentially cleaner than methods that rely on double-strand breaks.

Different gene-editing tools make different kinds of changes to DNA.

Why scientists are excited about it

Prime editing stands out because it targets a central problem in genetic medicine: many diseases are caused by small DNA changes, and those small changes need careful repair.

Scientists estimate that a large percentage of known disease-causing genetic variants (mutations) are the kinds of small changes prime editing was designed to address. That does not mean prime editing can treat all of them today. The editor still has to reach the right cells, work well enough, and avoid harmful side effects. Yet the match between the tool and the problem is promising.

Its appeal comes from several strengths.

It avoids full double-strand breaks

This may reduce some risks linked to classic CRISPR editing, including unwanted insertions and deletions at the target site.

It can make many edit types

Prime editing can correct single-letter mutations, insert short sequences, and delete short sequences.

It does not require a separate donor DNA template

Some older repair-based editing methods depend on the cell copying from a supplied DNA template. Many cells do this poorly. Prime editing carries the edit inside the guide RNA itself.

It can be programmed

Scientists can design different pegRNAs to target different DNA sequences, much like changing a software instruction, though biology is far less predictable than software.

Recent advances are making prime editing more practical

The first prime editing systems were impressive, but early versions had limits. Some edits worked well, while others worked poorly. Some cells accepted the editor more readily than others. Since then, researchers have improved nearly every part of the system.

Better prime editors have increased efficiency

Newer versions of prime editors have included changes to the Cas9 nickase, the reverse transcriptase, and the way the editor is expressed in cells. Systems often described as improved or enhanced prime editors have shown better editing efficiency in many lab settings.

Researchers have also worked on the balance between making the desired edit and avoiding unwanted side edits. One strategy, sometimes called PE3, nicks the unedited DNA strand after the first edit is installed. This can encourage the cell to keep the edited version. Other versions try to improve accuracy by tuning how and when that second nick happens.

Improved guide RNAs last longer in cells

A pegRNA has to survive long enough to guide the editor and provide the repair template. Standard pegRNAs can break down inside cells. Engineered pegRNAs, often called epegRNAs, include structural changes that help protect them.

This advance has been important because guide RNA stability can have a large effect on editing success. Better guides can mean more cells receive the intended edit.

Twin prime editing can handle larger changes

One important development is twin prime editing. Instead of using one pegRNA, twin prime editing uses two. Each guide works on a different strand or nearby site, allowing researchers to create larger insertions, deletions, inversions, or sequence replacements than standard prime editing can usually manage.

This could expand the range of mutations that prime editing can address. It also shows how the platform can be adapted rather than treated as one fixed tool.

Delivery methods are improving

Getting the editor into the right cells remains one of the biggest challenges. Prime editors are relatively large molecular machines, which makes delivery harder.

Researchers are testing several routes:

• Viral vectors, including split systems that package parts of the editor separately

• Lipid nanoparticles, similar in concept to delivery systems used for some RNA medicines

• Edited cells outside the body, which are then returned to the patient

• Smaller or engineered editor components that are easier to deliver

• Virus-like particles (VLPs) to deliver the editor to the appropriate cells.

  
  

In medicine, delivery often decides whether a gene-editing idea can become a treatment. A perfect editor in a dish is not enough. It must reach the right tissue, enter enough cells, and stop working after it has done its job.

Prime editing research depends on safe ways to deliver editing tools into cells.

Potential uses in medicine

Medical applications are the area that has attracted the most public attention. If a disease is caused by a known DNA error, prime editing might be able to correct it.

This post is informational only and is not medical advice. Prime editing therapies are still being studied, and any real treatment must go through careful testing for safety and effectiveness.

Inherited blood disorders

Blood disorders are a strong early target because blood-forming stem cells can be removed, edited in a lab, analyzed, and returned to the patient. This approach gives scientists more control than editing directly inside the body.

Preclinical research has explored prime editing for mutations linked to conditions such as sickle cell disease and beta thalassemia. These diseases involve hemoglobin, the protein in red blood cells that carries oxygen. Some strategies aim to correct disease-causing mutations directly, while others adjust related genes.

Eye diseases

The eye is another appealing target for gene editing. It is small, relatively accessible, and doctors can monitor changes closely. Some inherited retinal diseases are caused by precise mutations, which makes them possible candidates for prime editing research.

Delivery remains difficult, especially because prime editors are large. Still, the eye may become one of the places where precise editors are tested successfully.

Liver and metabolic diseases

The liver naturally takes up many particles from the blood, including some types of medicine delivery vehicles. That makes it a major target for genetic therapies.

Researchers have studied prime editing approaches for genes involved in cholesterol control, metabolic disease, and rare liver disorders. Many of these efforts are still in animals or cells, but they help test whether prime editing can work inside living tissue.

Neuromuscular and rare genetic diseases

Some rare diseases involve small DNA mutations that prime editing could, in theory, correct. Examples include certain forms of muscular dystrophy, enzyme deficiencies, and nervous system disorders.

The technical barriers are high. Muscle and brain tissue can be hard to reach. Long-term safety also matters because many of these tissues do not renew quickly. Even so, the precision of prime editing makes it an important tool for studying these diseases in cells and animal models.

Potential uses in agriculture

Prime editing is not only a medical tool, but it could also help plant scientists create crops with useful traits while making smaller DNA changes than older breeding or editing methods.

In agriculture, possible uses include:

• Improving resistance to plant diseases

• Helping crops tolerate drought, heat, or salty soil

• Changing oil, starch, or protein content

• Reducing natural toxins or allergens in certain foods

• Extending shelf life by slowing spoilage

  
  

Researchers have tested prime editing in important crops such as rice, wheat, maize, and tomatoes. Plant cells can be challenging to edit, and each species has its own barriers. Still, progress has been steady as scientists adapt the editor, improve guide design, and refine plant delivery methods.

One reason prime editing matters for agriculture is that it may produce changes similar to those that could happen through natural mutation or conventional breeding, but faster and with more precision. Regulations differ by country and by the type of edit, so the path from lab plant to farm field can vary widely.

Plant researchers are testing prime editing for crop traits such as resilience and nutrition.

The ethical questions are as important as the science

Prime editing raises familiar gene-editing questions, but its precision makes some of them feel more urgent. If editing becomes safer and easier, society will need clear rules for when it should be used.

Treating disease is different from enhancing traits

Many people see a strong ethical case for correcting serious disease-causing mutations, especially when no good treatment exists. The debate becomes harder when editing is used for nonmedical traits.

Changing traits such as height, appearance, athletic ability, or intelligence would raise questions about fairness, social pressure, and what kinds of human variation society values. In many cases, these traits are also shaped by many genes and the environment, so they are not simple editing targets.

Heritable editing needs special caution

Editing body cells affects only the treated person. Editing embryos, eggs, or sperm could pass changes to future generations. That raises much deeper ethical concerns because future people cannot consent, and any mistake could be inherited.

Many scientific and policy groups have urged strong limits on heritable human genome editing. Prime editing does not remove those concerns. If anything, a more precise tool increases the need for public oversight.

Access could shape who benefits

Advanced genetic therapies can be expensive and complex. If prime editing becomes a medical treatment, access will matter. A therapy that only reaches wealthy patients or well-funded health systems could widen existing health gaps.

The same concern applies to agriculture. Large seed companies may be better positioned to use advanced editing tools than small farmers or public breeding programs. Policies, licensing choices, and public research funding will affect who gains from the technology.

Safety must stay central

Precision does not mean perfection. Prime editing can still cause unintended edits, incomplete edits, immune reactions, or delivery-related problems. Researchers must also study long-term effects, especially for edits made in stem cells or tissues that persist for years.

Careful measurement matters. Scientists need to check not only whether the desired edit happened, but also whether other changes occurred elsewhere in the genome or at nearby sites.

What to watch next

Prime editing is moving from proof-of-concept studies toward more practical tests. The next stage will likely focus on a few key questions.

Can researchers deliver prime editors safely to the right tissues? Can they edit enough cells to make a real clinical difference? Can they reduce unwanted edits to very low levels? Can manufacturing be done at a scale that makes therapies available beyond a small number of patients?

In agriculture, the questions are slightly different. Can prime editing work reliably across major crops? Will edited plants perform well outside controlled settings? How will regulators classify small, precise DNA changes? Will consumers trust foods developed with these tools?

The answers will come gradually. Prime editing is not magic, and it will not replace every form of gene editing. Classic CRISPR, base editing, RNA editing, and conventional breeding will all remain useful. The value of prime editing is that it adds a powerful option to precisely rewrite DNA for changes that older tools cannot handle as well.

Traditional gene editing often cuts DNA and lets the cell repair it. Base editing changes certain letters. Prime editing specifies both the locus and the code, then writes the change into the genome.

This ability could reshape how scientists study disease, design therapies, and breed future crops. Scientists will have to work very slowly and carefully. If they can pair precision with safety, fairness, and trustworthyness, prime editing may become one of the most useful tools ever added to the genetic toolkit.